Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Pliant Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 100 | 3 | 98 | +1 |
| Shares | 50.4M | 76.4K | 46.7M | −3.59M (−7.1%) |
| Value | $74.7M | $113.0K | $57.0M | −$17.6M (−23.6%) |
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Pliant Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BML Capital Management, LLC | 1,546,137 | $1.89M | 1.67% |
| Centiva Capital, LP | 1,000,000 | $1.22M | 0.07% |
| Seven Fleet Capital Management LP | 276,500 | $337.3K | 0.23% |
| Laurion Capital Management LP | 257,400 | $314.0K | 0.02% |
| Nano Cap New Millennium Growth Fund L P | 235,000 | $286.7K | 0.24% |
| Diadema Partners LP | 144,914 | $176.8K | 0.11% |
| Kotler Kevin | 93,000 | $113.5K | 0.08% |
| ADAR1 Capital Management, LLC | 73,819 | $90.1K | 0.01% |
| Canada Pension Plan Investment Board | 61,400 | $74.9K | 0.00% |
| Deeter Investments LLP | 48,025 | $58.6K | 0.01% |
| Persistent Asset Partners Ltd | 38,831 | $47.4K | 0.02% |
| HRT Financial LP | 32,205 | $39.0K | 0.00% |
| Bronte Capital Management Pty Ltd. | 18,613 | $22.7K | 0.00% |
| Bare Financial Services, Inc | 413 | $504 | 0.00% |
| Cornerstone Financial Management LLC | 319 | $389 | 0.00% |
Sold out (14)
Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Great Point Partners LLC | 850,000 | $1.26M |
| Voleon Capital Management LP | 149,041 | $220.6K |
| Catalyst Funds Management Pty Ltd | 59,539 | $88.1K |
| Bluefin Capital Management, LLC | – | $61.0K |
| Jain Global LLC | 25,037 | $37.1K |
| FNY Investment Advisers, LLC | 25,400 | $37.0K |
| Tower Research Capital LLC (TRC) | 20,749 | $30.7K |
| China Universal Asset Management Co., Ltd. | 10,760 | $15.9K |
| Citigroup Inc | 4,319 | $6.39K |
| Mirae Asset Global Investments Co., Ltd. | 2,373 | $3.51K |
| GF Fund Management Co. Ltd. | 1,264 | $1.87K |
| Rise Advisors, LLC | 740 | $1.09K |
| Bell Investment Advisors, Inc | 307 | $455 |
| Daiwa Securities Group Inc. | 196 | $0 |
Not filed for Q4 2025 yet (3)
Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 54,367 | $80.5K |
| Point72 Asia (Singapore) Pte. Ltd. | 21,905 | $32.4K |
| Point72 (DIFC) Ltd | 112 | $166 |